Moderna (MRNA) Q3 earnings report 2023: Covid vaccine losses
Moderna on Thursday posted a steep loss for the third quarter as it recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product, and unveiled plans to scale back production of the shot. Moderna's total revenue for the period topped Wall Street's expectations, even...